容百科技(688005.SH):富鋰錳基正極材料樣品已送樣國內外多家電芯企業進行測試,處於市場領先水平
格隆匯7月3日丨有投資者向容百科技(688005.SH)提問,“目前公司的富鋰錳基正極材料進展如何?樣品是否已經已通過下游客户驗證?富鋰錳基正極材料目前在市場處於什麼階段?”
容百科技回覆稱,公司的富鋰錳基正極材料樣品已送樣國內外多家電芯企業進行測試,處於市場領先水平。當前富鋰錳基正極材料整體處於研發階段,還需要提高倍率性能、抑制循環及存儲過程的電壓衰減等技術問題,若解決技術瓶頸,富鋰錳基正極材料將成為極具潛力的下一代鋰離子電池正極材料,廣泛應用在汽車、儲能、小動力、數碼等各領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.